Dermavant Sciences

Dermavant Sciences is owned by Sumitomo Chemical.

Sumitomo Chemical is one of the...

• Forbes Global 2000 (#1009);
• Nikkei 225;
• Topix.

Sumitomo Chemical is a company listed under the stock ticker 4005 (JP).

Sumitomo Chemical has a direct presence in 6 countries.

Sumitomo Chemical has 28 subsidiaries including Asahi Chemical, Ciox Health and Covant Therapeutics.

They are in:

• Biotechnology55%
• Chemicals24%
• Other21%

View the org chart displaying its 23 main executives

Most searched biographies at Dermavant Sciences

• Todd Zavodnick, Chief Executive Officer
• Timothy Nelson, Director
• Frank Torti, Chairman of the Board

Create your alert
to follow the executive moves at Dermavant Sciences.

Sumitomo Chemical has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Dermavant Sciences

• News – Dermavant
• News – Dermavant

Social media about Dermavant Sciences

• Dermavant Sciences on Wikipedia, Google News & Yahoo Finance
• Dermavant Sciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Todd Zavodnick

Call Dermavant Sciences at +1 919...

View the org chart

Register to receive your alert

Report an error